HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sylvia Adams Selected Research

Epidermal Growth Factor (EGF)

8/2017A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.
10/2016Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sylvia Adams Research Topics

Disease

56Neoplasms (Cancer)
08/2023 - 10/2004
48Breast Neoplasms (Breast Cancer)
01/2024 - 12/2010
17Triple Negative Breast Neoplasms
04/2024 - 01/2013
9Neoplasm Metastasis (Metastasis)
10/2021 - 12/2012
8Melanoma (Melanoma, Malignant)
12/2019 - 07/2007
4Disease Progression
01/2023 - 01/2017
4Testicular Neoplasms (Testicular Cancer)
03/2015 - 07/2007
3Brain Neoplasms (Brain Tumor)
04/2024 - 11/2017
2Pathologic Complete Response
01/2023 - 01/2020
2Neutropenia
01/2020 - 03/2014
2Necrosis
10/2019 - 05/2015
2Noninfiltrating Intraductal Carcinoma (DCIS)
10/2019 - 09/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2018 - 11/2017
2Carcinoma (Carcinomatosis)
11/2017 - 05/2015
1Colonic Neoplasms (Colon Cancer)
01/2023
1COVID-19
01/2022
1Pleural Effusion (Pleural Effusions)
10/2021
1Ovarian Neoplasms (Ovarian Cancer)
10/2021
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
01/2021
1Genomic Instability
11/2020
1Peripheral Nervous System Diseases (PNS Diseases)
01/2020
1Autoimmune Hepatitis
01/2020
1Septic Shock (Toxic Shock Syndrome)
01/2020
1Liver Failure
01/2020
1Fatigue
01/2020
1Basal Cell Carcinoma (Rodent Ulcer)
12/2019
1Carcinoma in Situ
10/2018
1Neoplasm Micrometastasis
09/2018
1Margins of Excision
09/2018
1Starvation
11/2017

Drug/Important Bio-Agent (IBA)

20Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2013
10Immune Checkpoint InhibitorsIBA
12/2021 - 10/2016
9130-nm albumin-bound paclitaxelIBA
11/2021 - 01/2016
7atezolizumabIBA
11/2021 - 11/2018
7Imiquimod (Aldara)FDA LinkGeneric
12/2019 - 07/2008
7AntigensIBA
10/2018 - 07/2007
6B7-H1 AntigenIBA
12/2021 - 01/2017
5Proteins (Proteins, Gene)FDA Link
03/2015 - 05/2007
4Estrogen ReceptorsIBA
01/2023 - 01/2016
4Hematoxylin (Haematoxylon)IBA
01/2023 - 09/2014
4CytokinesIBA
01/2019 - 11/2008
4Hormones (Hormone)IBA
11/2018 - 01/2013
3Messenger RNA (mRNA)IBA
01/2023 - 11/2008
3pembrolizumabIBA
01/2023 - 01/2017
3Eosine Yellowish-(YS) (Eosin)IBA
01/2023 - 09/2015
3RNA (Ribonucleic Acid)IBA
01/2023 - 01/2021
3taxaneIBA
01/2021 - 11/2018
3Paclitaxel (Taxol)FDA LinkGeneric
08/2017 - 12/2010
3MART-1 AntigenIBA
08/2011 - 08/2008
2Peptides (Polypeptides)IBA
01/2023 - 07/2007
2IpilimumabIBA
01/2022 - 08/2011
2PlatinumIBA
01/2020 - 03/2014
2Monoclonal AntibodiesIBA
01/2019 - 10/2018
2human ERBB2 proteinIBA
11/2018 - 01/2013
2Toll-Like Receptors (Toll-Like Receptor)IBA
10/2018 - 12/2012
2Toll-Like Receptor AgonistsIBA
10/2018 - 11/2009
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2018 - 12/2012
2Matrix Metalloproteinase InhibitorsIBA
01/2018 - 10/2016
2Matrix Metalloproteinases (MMPs)IBA
01/2018 - 10/2016
2Epidermal Growth Factor (EGF)IBA
08/2017 - 10/2016
2Monatide (IMS 3015)IBA
03/2015 - 05/2007
2Toll-Like Receptor 7IBA
12/2012 - 12/2012
2Monophenol Monooxygenase (Tyrosinase)IBA
08/2011 - 08/2008
2Vaccine AdjuvantsIBA
11/2009 - 07/2008
1Progesterone Receptors (Progesterone Receptor)IBA
01/2023
1ApolipoproteinsIBA
01/2023
1TamoxifenFDA LinkGeneric
11/2022
1Aromatase InhibitorsIBA
11/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1NivolumabIBA
01/2022
1InterferonsIBA
10/2021
1monophosphoryl lipid AIBA
10/2021
1SodiumIBA
01/2021
1Protons (Proton)IBA
01/2021
1trans-sodium crocetinate (crocetin)IBA
01/2021
1Small Cytoplasmic RNAIBA
01/2021
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
11/2020
1Phenobarbital (Luminal)FDA Link
11/2020
1DNA Repair EnzymesIBA
11/2020
1ChemokinesIBA
12/2019
1LigandsIBA
01/2019
1Chemokine CXCL10IBA
01/2019
1Blocking AntibodiesIBA
01/2019
1Immunoconjugates (Immunoconjugate)IBA
10/2018
1Cytotoxins (Cytolysins)IBA
10/2018
1exemestane (Aromasin)FDA Link
02/2018
1fresolimumabIBA
01/2018
1Oxygen (Dioxygen)IBA
11/2017
1Glutathione (Reduced Glutathione)IBA
11/2017
1IronIBA
11/2017
1EnzymesIBA
11/2017

Therapy/Procedure

26Therapeutics
04/2024 - 11/2008
12Immunotherapy
01/2021 - 10/2004
10Drug Therapy (Chemotherapy)
11/2022 - 05/2015
6Radiotherapy
09/2018 - 12/2010
3Neoadjuvant Therapy
01/2023 - 09/2018
2Adjuvant Chemotherapy
09/2015 - 05/2015
1Biological Therapy
01/2022
1Segmental Mastectomy (Lumpectomy)
10/2019
1Mastectomy (Mammectomy)
09/2018